The forecast for breast cancer screening coverage in the Netherlands indicates a consistent decline from 2024 to 2028, with values dropping from 58.2% in 2024 to 46.3% in 2028. This represents a year-on-year decrease, showcasing a negative trend in screening coverage. The annual percentage decrease over the five-year period suggests a need for intervention to counteract this downward trajectory.
Looking ahead, it’s crucial to monitor factors contributing to the decline in screening coverage, such as changes in healthcare policy, screening program accessibility, and public awareness. Innovations in screening technology and efforts to enhance healthcare infrastructure could reverse this trend, improving early detection rates and ultimately, patient outcomes in the Netherlands.
